FDA PMA FDA Class 3 Approved 🇺🇸 United States

Separator For Therapeutic Purposes, Membrane Automated Blood Cell/Plasma

PMA: P830063 · Supplement: S006 · Decision Jun 17, 2011
Classifications
1
FEI Numbers
5
Registration Numbers
5

Basic Information

Device Name
Separator For Therapeutic Purposes, Membrane Automated Blood Cell/Plasma
Trade Name
PRISMAFLEX TPE 2000 SET
PMA Number
P830063
Supplement Number
S006
Device Class
FDA Class 3
Product Code
MDP
Generic Name
Separator for therapeutic purposes, membrane automated blood cell/plasma
Medical Specialty
Unknown
Advisory Committee
Gastroenterology, Urology
Decision
Approved
Decision Code
APPR
Decision Date
June 17, 2011
Date Received
October 9, 2007
Supplement Type
Real-Time Process
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR MODIFICATIONS TO THE GAMBRO PRISMA TPE 2000 SET WITH PLASMAFILTER PF 2000N TO PERMIT THE USE OF THE PLASMAFILTER WITH THE GAMBRO PRISMAFLEX SYSTEM. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME PRISMAFLEX TPE 2000 SET AND IS INDICATED FOR THERAPEUTIC PLASMAPHERESIS.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MDP Separator For Therapeutic Purposes, Membrane Automated Blood Cell/Plasma